Yan-Qun Xiang Selected Research

TP protocol

1/2022	Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial.
1/2022	Effect of Capecitabine Maintenance Therapy Plus Best Supportive Care vs Best Supportive Care Alone on Progression-Free Survival Among Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma Who Had Received Induction Chemotherapy: A Phase 3 Randomized Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yan-Qun Xiang Research Topics

Disease

63	Nasopharyngeal Carcinoma 02/2024 - 10/2004
27	Neoplasms (Cancer) 02/2024 - 03/2004
26	Neoplasm Metastasis (Metastasis) 02/2024 - 03/2004
3	Mucositis 01/2022 - 01/2017
2	Necrosis 08/2023 - 01/2016
2	Vomiting 01/2022 - 01/2018
2	Disease Progression 01/2022 - 01/2020
2	Nausea 01/2022 - 01/2018
2	Carcinogenesis 01/2019 - 01/2017
1	Hypertension (High Blood Pressure) 08/2023
1	Anaphylaxis (Anaphylactic Shock) 08/2023
1	Hemorrhage 08/2023
1	Pruritus (Itching) 08/2023
1	Fatigue 01/2022
1	Anemia 01/2022
1	Hand-Foot Syndrome 01/2022
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Neutropenia 01/2021
1	Anorexia 01/2018
1	Ototoxicity 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Weight Loss (Weight Reduction) 01/2017
1	Candidiasis (Moniliasis) 01/2017
1	Sinusitis 08/2008
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2004

Drug/Important Bio-Agent (IBA)

11	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 04/2013
10	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2014
6	PlatinumIBA 08/2023 - 02/2010
6	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 02/2010
6	Indicators and Reagents (Reagents)IBA 01/2020 - 10/2004
5	3-nitrophenyl 3-piperidinecarboxylate (MNPC)IBA 08/2023 - 01/2013
4	Capecitabine (Xeloda)FDA Link 10/2022 - 01/2022
3	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2021
3	C-Reactive ProteinIBA 10/2023 - 01/2013
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2023 - 10/2004
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2011
3	Carboplatin (JM8)FDA LinkGeneric 01/2016 - 02/2010
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2023 - 01/2021
2	AntibodiesIBA 08/2023 - 11/2015
2	IntegrinsIBA 01/2023 - 01/2019
2	Neurofibromin 2 (Merlin)IBA 01/2023 - 01/2019
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2022 - 08/2013
2	lobaplatinIBA 01/2021 - 01/2017
2	Docetaxel (Taxotere)FDA Link 01/2016 - 02/2010
1	apatinibIBA 02/2024
1	Angiogenesis InhibitorsIBA 02/2024
1	camrelizumabIBA 02/2024
1	sintilimabIBA 08/2023
1	Bevacizumab (Avastin)FDA Link 08/2023
1	BilirubinIBA 08/2023
1	Complement System Proteins (Complement)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Polo-Like Kinase 1IBA 01/2019
1	BI 6727IBA 01/2019
1	taxaneIBA 10/2018
1	nedaplatinIBA 01/2018
1	130-nm albumin-bound paclitaxelIBA 01/2017
1	potassium hydroxideIBA 01/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2017
1	SolventsIBA 01/2017
1	Cetuximab (Erbitux)FDA Link 01/2017
1	Albumin-Bound Paclitaxel FDA Link 01/2017
1	Hepatitis B Core AntigensIBA 11/2015
1	Urokinase Plasminogen Activator ReceptorsIBA 01/2014
1	Matrix Metalloproteinases (MMPs)IBA 12/2013
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 12/2013
1	Proteins (Proteins, Gene)FDA Link 04/2013
1	raf KinasesIBA 04/2013
1	Small Interfering RNA (siRNA)IBA 07/2012
1	Interleukin-8 (Interleukin 8)IBA 07/2012
1	Proteoglycans (Proteoglycan)IBA 04/2011
1	serglycinIBA 04/2011
1	ProteomeIBA 08/2010
1	Immunoglobulin A (IgA)IBA 02/2006
1	ErbB Receptors (EGF Receptor)IBA 11/2004
1	Tyrosine Kinase InhibitorsIBA 11/2004
1	Gefitinib (Iressa)FDA Link 11/2004
1	anilinoquinazolineIBA 11/2004

Therapy/Procedure

21	Chemoradiotherapy 02/2024 - 10/2009
19	Radiotherapy 10/2023 - 03/2004
16	Drug Therapy (Chemotherapy) 10/2023 - 02/2010
13	Induction Chemotherapy 02/2024 - 10/2009
7	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2021 - 12/2015
5	Therapeutics 10/2023 - 12/2011
2	TP protocol 01/2022 - 01/2022
2	Precision Medicine 01/2017 - 04/2011
2	Aftercare (After-Treatment) 06/2011 - 11/2004
1	Immunotherapy 02/2024
1	Combination Drug Therapy (Combination Chemotherapy) 01/2023
1	Adjuvant Chemotherapy 10/2022
1	Neoadjuvant Therapy 01/2017
1	Re-Irradiation 01/2016
1	Lasers (Laser) 08/2010